607 related articles for article (PubMed ID: 12474226)
21. Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa).
Zhao J; Richter J; Wagner U; Roth B; Schraml P; Zellweger T; Ackermann D; Schmid U; Moch H; Mihatsch MJ; Gasser TC; Sauter G
Cancer Res; 1999 Sep; 59(18):4658-61. PubMed ID: 10493521
[TBL] [Abstract][Full Text] [Related]
22. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer.
Simon R; Bürger H; Brinkschmidt C; Böcker W; Hertle L; Terpe HJ
J Pathol; 1998 Aug; 185(4):345-51. PubMed ID: 9828832
[TBL] [Abstract][Full Text] [Related]
24. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
Bartoletti R; Cai T; Nesi G; Roberta Girardi L; Baroni G; Dal Canto M
J Surg Res; 2007 Dec; 143(2):422-7. PubMed ID: 17612565
[TBL] [Abstract][Full Text] [Related]
25. Partial allelotype of carcinoma in situ of the human bladder.
Rosin MP; Cairns P; Epstein JI; Schoenberg MP; Sidransky D
Cancer Res; 1995 Nov; 55(22):5213-6. PubMed ID: 7585577
[TBL] [Abstract][Full Text] [Related]
26. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
[TBL] [Abstract][Full Text] [Related]
27. Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features.
Mazzucchelli R; Barbisan F; Stramazzotti D; Montironi R; Lopez-Beltran A; Scarpelli M
Anal Quant Cytol Histol; 2005 Jun; 27(3):143-51. PubMed ID: 16121635
[TBL] [Abstract][Full Text] [Related]
28. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.
Zhang ZT; Pak J; Huang HY; Shapiro E; Sun TT; Pellicer A; Wu XR
Oncogene; 2001 Apr; 20(16):1973-80. PubMed ID: 11360181
[TBL] [Abstract][Full Text] [Related]
29. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis.
Hartmann A; Rösner U; Schlake G; Dietmaier W; Zaak D; Hofstaedter F; Knuechel R
Lab Invest; 2000 May; 80(5):709-18. PubMed ID: 10830781
[TBL] [Abstract][Full Text] [Related]
30. [FISH analysis in the differential diagnosis of flat urothelial lesions using tissue microarrays].
Schwarz S; Rechenmacher M; Lottner C; Brockhoff G; Hartmann A; Langer S; Knüchel R
Verh Dtsch Ges Pathol; 2004; 88():184-93. PubMed ID: 16892551
[TBL] [Abstract][Full Text] [Related]
31. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract.
Takahashi T; Habuchi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Yoshida O
Cancer Res; 1998 Dec; 58(24):5835-41. PubMed ID: 9865743
[TBL] [Abstract][Full Text] [Related]
32. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer.
Chow NH; Cairns P; Eisenberger CF; Schoenberg MP; Taylor DC; Epstein JI; Sidransky D
Int J Cancer; 2000 Nov; 89(6):514-8. PubMed ID: 11102896
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.
Adams J; Williams SV; Aveyard JS; Knowles MA
Cancer Res; 2005 Jan; 65(1):66-75. PubMed ID: 15665280
[TBL] [Abstract][Full Text] [Related]
34. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
35. A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder.
Roperto S; Borzacchiello G; Brun R; Leonardi L; Maiolino P; Martano M; Paciello O; Papparella S; Restucci B; Russo V; Salvatore G; Urraro C; Roperto F
J Comp Pathol; 2010; 142(2-3):95-108. PubMed ID: 19818448
[TBL] [Abstract][Full Text] [Related]
36. High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis.
Koene GJ; Arts-Hilkes YH; van der Ven KJ; Rozemuller EH; Slootweg PJ; de Weger RA; Tilanus MG
Tissue Antigens; 2004 Oct; 64(4):452-61. PubMed ID: 15361122
[TBL] [Abstract][Full Text] [Related]
37. Y chromosome loss is a frequent early event in urothelial bladder cancer.
Minner S; Kilgué A; Stahl P; Weikert S; Rink M; Dahlem R; Fisch M; Höppner W; Wagner W; Bokemeyer C; Terracciano L; Simon R; Sauter G; Wilczak W
Pathology; 2010 Jun; 42(4):356-9. PubMed ID: 20438408
[TBL] [Abstract][Full Text] [Related]
38. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
Knowles MA; Shaw ME; Proctor AJ
Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
[TBL] [Abstract][Full Text] [Related]
39. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
Lane Z; Epstein JI
Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
[TBL] [Abstract][Full Text] [Related]
40. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
